Dr. Elliot Newman, MD

Dr. Newman practices at Lenox Hill Hospital in New York, New York, part of Northwell Health.

Dr. Newman's NPI, 1568453686, was assigned on October 31, 2005. Dr. Newman graduated from New York University Grossman School of Medicine in 1986. Dr. Newman holds New York license 170584.

Dr. Newman's primary practice is Lenox Hill Hospital, at 100 East 77th Street, New York, NY 10075 in New York County. The practice phone is (212) 434-2000.

Dr. Newman's primary practice is Lenox Hill Hospital in New York, New York, part of Northwell Health. The medical group on file is Northwell Health Physician Partners Cardiology at Great Neck. Dmand AI also links Dr. Newman to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Newman practices, 3 sites in all. Vendor and product names are available with a free account.

Surgical oncology is Dr. Newman's primary specialty in the NPI Registry, under taxonomy code 2086X0206X. Dr. Newman is licensed in New York.

CMS data shows 215 Medicare services from Dr. Newman across 5 procedure codes in 2024, for 148 Medicare patients. Medicare paid $19,335 for them.

CMS counts 148 Medicare patients who saw Dr. Newman in 2024. The largest group is 75 to 84, with 72 patients. 75% of them have high cholesterol, and 73% have high blood pressure. 13% are also on Medicaid. Their average risk score is 1.58, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Newman's median patient age at 72, with 52% women.

In 2024, Dr. Newman wrote 69 Medicare Part D claims for 30 patients. 57% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $31 in total drug cost. In 2018, CMS named 25 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Newman for performance year 2024, reported through an alternative payment model (APM). Dr. Newman accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Newman as offering telehealth.

Colonoscopy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 41 papers to Dr. Newman, published from 2010 to 2025. 2024 was the busiest year, with 8. The most frequent topics are Pancreatic Neoplasms, Postoperative Complications and Pancreaticoduodenectomy. Dr. Newman has published most often in Ann Surg Oncol. Dr. Newman's most frequent co-authors are Marcovalerio Melis, MD, Matthew Weiss, MD and Russell Scott Berman, MD.

Dmand AI links Dr. Newman to 1 clinical trial. Conditions studied include Pancreatic Neoplasms and Pancreatic Diseases.

CMS Open Payments shows 12 general payments to Dr. Newman from 4 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 55% of the total. Delcath Systems paid the most, $458.

Dr. Newman graduated from New York University Grossman School of Medicine in 1986.